XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 56 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $451,000 | +162.2% | 99,860 | +185.1% | 0.00% | – |
| Q4 2020 | $172,000 | +12.4% | 35,031 | +35.9% | 0.00% | – |
| Q3 2020 | $153,000 | +188.7% | 25,772 | +29.4% | 0.00% | – |
| Q2 2020 | $53,000 | +96.3% | 19,915 | +46.3% | 0.00% | – |
| Q1 2020 | $27,000 | -59.7% | 13,617 | +40.7% | 0.00% | – |
| Q4 2019 | $67,000 | -8.2% | 9,675 | +28.3% | 0.00% | – |
| Q3 2019 | $73,000 | -68.1% | 7,539 | -62.7% | 0.00% | – |
| Q2 2019 | $229,000 | -33.8% | 20,221 | -41.5% | 0.00% | – |
| Q1 2019 | $346,000 | +208.9% | 34,578 | +415.8% | 0.00% | – |
| Q4 2018 | $112,000 | -77.4% | 6,704 | -76.3% | 0.00% | – |
| Q3 2018 | $495,000 | – | 28,287 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|